Similarly, in the breast cancer cell lines, MCF-7 and T47D, co-IP and GST-pulldown experiments revealed that EZH2 was found to interact with ERα and β-CATENIN and to induce the transcription of their target genes. The gene discussed is EZH2; the disease is breast cancer.